2022 American Transplant Congress

June 4-8, 2022 in Boston, MA

The ATC program is built in the Eastern Time Zone.

View by Title View Sessions View Topics

View by Date

Tuesday, June 7, 2022

7:00pm-8:00pm: Duration of Brain Death Does Not Impact Short Term Outcomes in Kidney Transplantation

A. M. Hawxby¹, R. Ketcham², J. P. Orlowski³, R. A. Squires², C. Hostetler²

Poster Chat: Organ Inclusive • Hynes Hall C

7:00pm-8:00pm: Early Experience with 4-drug Maintenance Immunosuppression in Kidney and Pancreas Transplant Recipients

S. Mouawad¹, C. Shoemaker², J. Geyston³, A. Nishio Lucar³

Kidney Immunosuppression: Novel Regimens and Drug Minimization • Hynes Halls C & D

7:00pm-8:00pm: Early Outcomes of Single Dose Eculizumab for Abo-Incompatible Living Donor Renal Transplantation

K. Heagler, M. Campara, P. Di Cocco, S. Gaitonde, I. Tang, J. Almario Alvarez, M. Spaggiari, J. Benken, C. S. Muran, B. Valdepenas, D. Pierce, I. Tzvetanov, E. Benedetti

Poster Chat: Kidney 1 • Hynes Hall C

7:00pm-8:00pm: Effect of Covid-19 Diagnosis on Organ Donation and Transplantation

L. Baetje¹, A. Cheng¹, S. Sander², L. Markham², M. Ott², J. Finn², A. Wee³, K. Dyer⁴, A. Atluri¹, D. Jahandar¹, M. Moncure⁴

Deceased Donor Management and Intervention Research • Hynes Halls C & D

7:00pm-8:00pm: Effect of Immunosuppression Withdrawal After Graft Failure on Re-Kidney Transplantation Outcomes

J. Ahn¹, S. Sandal², S. Bae¹, D. Segev¹, M. McAdams-DeMarco¹

Kidney Immunosuppression: Novel Regimens and Drug Minimization • Hynes Halls C & D

7:00pm-8:00pm: Effect of Micafungin Bridging on Prevention of Invasive Candidiasis Post Lung Transplantation

C. Baladad¹, M. Converse¹, K. DeSear¹, S. Karimi¹, E. Rubido¹, G. El Helou², T. Pasley¹

Pharmacy II • Hynes Halls C & D

7:00pm-8:00pm: Effect of Sars-CoV-2 Delta Variant on Post-Vaccination COVID-19 Infection in Solid Organ Transplant Recipients

E. Tuttle¹, J. Moon², T. J. Grazia³, T. Sam⁴, S. Mathai³

All Infections (Excluding Kidney & Viral Hepatitis) IV • Hynes Halls C & D

7:00pm-8:00pm: Effectiveness and Limitations of PK Analysis in Optimization of Immunosuppressive Therapy for Kidney Transplantation

M. Okumura, K. Ishiyama, S. Ashimine, Y. Miwa, K. Iwasaki, T. Kobayashi

Pharmacy II • Hynes Halls C & D

7:00pm-8:00pm: Efficacy and Safety of Delayed, Low-Dose Valganciclovir in High-Risk Cytomegalovirus Liver Transplant Recipients

S. Anders¹, A. Freeman¹, L. Hutchinson¹, U. Kaszubski¹, M. Janusek¹, A. Hooter², D. Raymond², C. Nguyen²

Pharmacy II • Hynes Halls C & D

7:00pm-8:00pm: Elevated Donor-Derived Cell-Free DNA (dd-cfDNA) in the Early Post-Transplant Period is Associated with an Increased Incidence of Adverse Clinical Outcomes in Kidney Transplant Recipients

D. Wojciechowski¹, A. Patel², S. Anand³, J. Klein⁴, A. Paramesh⁵, P. Sood⁶, G. Shekhtman⁷, N. Agrawal⁷, M. Fei⁷, K. Qu⁷, D. C. Brennan⁸

Biomarkers: Clinical Outcomes • Hynes Halls C & D